PP13. PHASE II STUDY OF THE SAFETY AND EFFICACY OF INFLIXIMAB IN GIANT CELL ARTERITIS (GCA): 22 WEEK INTERIM ANALYSIS.
Autor: | G. S. Hoffman, M. C. Cid, C. M. Weyand, J. H. Stone, K. E. Rendt, C. Salvarani, P. A. Merkel, W. Xu, S. Visvanathan, M. U. Rahman |
---|---|
Zdroj: | Rheumatology; Mar2005, Vol. 44 Issue 3, piii18-iii18, 1p |
Databáze: | Complementary Index |
Externí odkaz: |